Datta Medicare And Finance (Enterprises) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 20.63%
(FY 2020)
- Profit 9.17%
(FY 2020)
- Ebitda 10.81%
(FY 2020)
- Net Worth 11.78%
(FY 2020)
- Total Assets 10.94%
(FY 2020)
About Datta Medicare And Finance (Enterprises)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Datta Panandikar and Bharati Panandikar serve as directors at the Company.
- CIN/LLPIN
U85110MH1989PTC051880
- Company No.
051880
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Datta Medicare And Finance (Enterprises)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Datta Panandikar  | Director | 25-May-1989 | Current |
| Bharati Panandikar | Director | 01-Sep-2009 | Current |
Financial Performance of Datta Medicare And Finance (Enterprises).
Datta Medicare And Finance (Enterprises) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.63% increase. The company also saw a slight improvement in profitability, with a 9.17% increase in profit. The company's net worth Soared by an impressive increase of 11.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Datta Medicare And Finance (Enterprises)?
In 2020, Datta Medicare And Finance (Enterprises) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medivision Diagnostics & Multispeciality Hospitals Private LimitedActive 15 years 8 monthsDatta Panandikar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Datta Medicare And Finance (Enterprises)?
Datta Medicare And Finance (Enterprises) has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Datta Medicare And Finance (Enterprises), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Datta Medicare And Finance (Enterprises)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
